Business
Statement regarding Mead Johnson
Statement regarding Mead Johnson.
About this update from Reckitt Benckiser Group Plc
[{"type":"text","content":"\n \nRNS Number : 8437V Reckitt Benckiser Group PLC 02 February 2017 \n\n \n \n \n \n \n2 February 2017\nTHIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION\n \n \nReckitt Benckiser Group plc\nStatement regarding Mead Johnson\nReckitt Benckiser Group plc (\"RB\") notes the recent press speculation regarding a possible transaction involving Mead Johnson Nutrition Company (\"Mead Johnson\").\n \nRB confirms that it is in advanced negotiations to acquire each Mead Johnson share for $90 in cash, valuing Mead Johnson's entire share capital at approximately $16.7 billion.\n \nThe parties are presently engaged in a period of due diligence and contract discussion.\n \nRB presently expects to finance the possible transaction through a combination of cash and debt, whilst retaining a strong investment grade credit rating.\n \nThere is no certainty that any transaction will ultimately be agreed, nor as to the terms on which any transaction might occur.\n \nA further announcement will be made as appropriate.\n \nFor further information, please contact:\n\n\n\n\nRB\nRichard Joyce\nSVP, Investor Relations, Communications & External Affairs\n \n\n\n \n+44 (0)1753 217800\n\n\n\n\nBrunswick (Financial PR)\nGabrielle Silver & David Litterick\n \n\n\n +44 (0)20 7404 5959\n \n\n\n\n\n \n\nThis information is provided by RNSThe company news service from the London Stock Exchange END STROKBDQABKKNBK\n ","length":2639,"tagName":"div"}]